Tul-id, Marife C.
HRN: 16-34-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/09/2023
05/16/2023
TOPICAL
1%
BID
Infected Wound, 2nd Digit Right Hand
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes